Antibacterial drugs in the form of sprays for the topical treatment of pyodermas and dermatoses complicated with a secondary infection

Cover Page


Cite item

Full Text

Abstract

The article covers issues related to the application of topical antibacterial drugs for the treatment of pyodermic skin diseases. The author describes mechanisms of action and advantages of the topical form of antibiotics and GCS for the topical treatment of pyodermas. The article substantiates indications for the administration of topical GCS drugs in a combination with antibacterial drugs. The efficacy and safety of antibacterial and combination topical drugs such as Neomycin, Oxycort and Polcortolon TC in the form sprays for the treatment of pyodermas and complicated forms of chronic dermatosis.

About the authors

YE. V. Matushevskaya

Institute of Improvement of professional skill of Federal Medico-Biological Agency of Russia

Author for correspondence.
Email: matushevskaya@mail.ru
Russian Federation

References

  1. European Task Force on Atopic Dermatitis Position paper on diagnosis and treatment of atopic dermatitis; 2005.
  2. Clinical recommendations of RODV. Atopic dermatitis, Moskva 2010. 40 c. [Клинические рекомендации РОДВ. Атопический дерматит, Москва 2010; 40.]
  3. Clinical recommendations. Psoriasis. RODV Mockva, 2008, 45 c. [Клинические рекомендации. Псориаз. РОДВ. Москва 2008; 45.]
  4. Clinical recommendations. Dermatovenereology. RODV Moskva 2010; 435. [Клинические рекомендации. Дерматовенерология РОДВ. Москва 2010; 435.]
  5. European S3-Guidelines on the systemic treatment of psoriasis vulgaris EADV 2009, Guidelines of care for the management of psoriasis and psoriatic arthritis. EADV 2011.
  6. Clinical recommendations. Dermatovenereology, Moskva 2010; 435. [Клинические рекомендации. Дерматовенерология, Москва 2010; 435.]
  7. García Ponte L., Ebert U. Frontiers of rapid itch relief: a review of methylprednisolone aceponate. J Eur Acad Dermatol Venereol 2012; 26 Suppl 6: 9-13.
  8. Blume-Peytavi U., Metz M. Atopic dermatitis in children: management of pruritus. J Eur Acad Dermatol Venereol 2012; 26 Suppl 6: 2-8.
  9. Ahluwalia A. Topical glucocorticoids and the skin-mechanisms of action: an update. Mediators Inflamm 1998; 7(3): 183-93.
  10. Ahluwalia A., Newbold P., Brain S.D., Flower R.J. Topical glucocorticoids inhibit neurogenic inflammation: involvement of lipocortin 1. Eur J Pharmacol 1995; 283 (1-3): 193-8.
  11. Nutan, Kanwar A.J., Bhansali A., Parsad D. Evaluation of hypothalamic-pituitary-adrenal axis in patients with atopic dermatitis. Indian J Dermatol Venereol Leprol 2011; 77(3): 288-93.
  12. Saraswat A., Lahiri K., Chatterjee M. et al. Topical corticosteroid abuse on the face: a prospective, multicenter study of dermatology outpatients. Indian J Dermatol Venereol Leprol 2011; 77(2): 160-6.
  13. Gong J.Q., Lin L., Lin T. et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol 2006; 155(4): 680-7.
  14. Schöfer H, Simonsen L. Fusidic acid in dermatology: an updated review. Eur J Dermatol 2010; 20(1): 6-15.
  15. Korotkiy N.G. Modern topical treatment of dermatoses (with elements of physiotherapy). Tver. "Gubernskaya meditsina”, 2001; 528. [Короткий Н.Г. Современная наружная терапия дерматозов (с элементами физиотерапии). Тверь. «Губернская медицина» 2001; 528.]
  16. Dubenskiy V.V., Garmonov A.A. Topical treatment of dermatoses. Rukovodstvo dlya vrachey. Tver 2007; 218. [Дубенский В.В., Гармонов А.А. Наружная терапия дерматозов. Руководство для врачей. Тверь 2007; 218.] Вестник дерматологии и венерологии Фармакотерапия в дерматовенерологии л 63
  17. Skripkin U.K., Hamaganova I.V. Experience of application of aerosols Oxycort and Polcortolon TC in the treatment of allergic dermatoses, complicated by pyoderma. Vestn dermatol i venerol 2004; 1; 42-43. [Скрипкин Ю.К., Хамаганова И.В. Опыт применения аэрозолей оксикорт и полькортолон ТС в лечении аллергических дерматозов, осложненных пиодермией. Вестн дерматол и венерол 2004; 1; 42-43.]
  18. Matushevskaya E.V., Svirshchevskaya E.V., Matushevskaya Yu.I. The use of Oxycort and Polcortolon TC in dermatological practice. Klin dermatol i venerol, 2008; 3: 35-37. [Матушевская Е.В., Свирщевская Е.В., Матушевская Ю.И. Применение препаратов оксикорт и полькортолон ТС в дерматологической практике. Клин дерматол и венерол, 2008; (3): 35-37.]
  19. Matushevskaya E.V., Svirshchevskaya E.V., Matushevskaya Yu.I. Modern approaches to the treatment of infectious inflammatory skin diseases. Sovr probl dermatovenerol, immunol i vrach kosmetol. 2013; 28 (VII): 57-61. [Матушевская Е.В., Свирщевская Е.В., Матушевская Ю.И. Современные принципы лечения инфекционно-воспалительных заболеваний кожи. Совр пробл дерматовенерол, иммунол и врач-косметол 2013; 28 (VIII): 57-61.]
  20. Aarestrup F.M., Lertworapreecha M., Evans M.C., Bangtrakulnonth A., Chalermchaikit T., Hendriksen R.S., Wegener H.C. Antimicrobial susceptibility and occurence of resistance genes among Salmonella enterica serovar Weltevreden from different countries. J Antimicrob Chemother 2003; 52: 715-718.
  21. Waksman SA, Lechevalier HA. Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms. Science. 1949; 109 (2830): 305-7.
  22. Panzer J.D., Epstein W.L. Percutaneous absorption following topical application of neomycin. Arch Derm 1970; 102: 536-539.
  23. Siegenthaler W.E., Bonetti A., Luthy R. Aminoglycoside antibiotics in infectious diseases. An overwiew. Am J Med 1986; 30: 2-14.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Matushevskaya Y.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies